Email This Article

Headlines & Perspectives
Introgen's 'Promise'
By Adam Feuerstein
03/07/07 - 12:03 PM EST
The approval timeline for its cancer gene therapy hasn't exactly remained stable.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,287.48 1,098.40 2,164.03 34.74
Oil *
77.48
UP
40.51
UP
5.39
UP
12.95
DOWN
0.08
10 Yr
3.47%
SPDR Gold
109.25
+0.40%
+0.49%
+0.60%
-0.23%
Data delayed 20 minutes

Brokerage Partners